Aimei Health Technology Co., Ltd
AFJK
$37.49
$4.4813.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 92.47% | 212.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 92.47% | 212.98% | |||
| Operating Income | -92.47% | -212.98% | |||
| Income Before Tax | -72.13% | -17.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -72.13% | -17.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -72.13% | -17.18% | |||
| EBIT | -92.47% | -212.98% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -67.13% | -17.15% | |||
| Normalized Basic EPS | -67.13% | -17.28% | |||
| EPS Diluted | -67.13% | -17.15% | |||
| Normalized Diluted EPS | -67.13% | -17.28% | |||
| Average Basic Shares Outstanding | -15.39% | 0.00% | |||
| Average Diluted Shares Outstanding | -15.39% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||